Literature DB >> 6383692

The role of opioid peptides in the hormonal responses to acute exercise in man.

A Grossman, P Bouloux, P Price, P L Drury, K S Lam, T Turner, J Thomas, G M Besser, J Sutton.   

Abstract

Opioid involvement in the physiological and hormonal responses to acute exercise was investigated in six normal male subjects. Each was exercised to 40% (mild exercise) and 80% (severe exercise) of his previously determined maximal oxygen consumption on two occasions, with and without an infusion of high-dose naloxone. The exercise task was a bicycle ergometer; mild and severe exercise were performed for 20 min each, followed by a recovery period. Exercise produced the expected increases in heart rate, blood pressure, ventilation, tidal volume, respiratory rate, oxygen consumption and carbon dioxide production. After severe exercise, naloxone infusion increased ventilation from 94.8 +/- 4.9 litres/min to 105.7 +/- 5.0 litres/min (P less than 0.05), but had no effect on any of the other physiological variables. Exercise-induced changes in several hormones and metabolites were noted, including elevations in circulating lactate, growth hormone (GH), prolactin, cortisol, luteinizing hormone (LH), follicle stimulating hormone (FSH), adrenaline noradrenaline, plasma renin activity (PRA) and aldosterone. There was no change in plasma met-enkephalin. Naloxone infusion produced the expected increases in LH and cortisol, but also significantly enhanced the elevations in prolactin, adrenaline, noradrenaline, plasma renin activity and aldosterone (P less than 0.05). Psychological questionnaires revealed minor mood changes after exercise, but no evidence was found for the suggested 'high' or euphoria of exercise. Effort was perceived as greater during the naloxone infusion than the saline infusion in every subject.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6383692     DOI: 10.1042/cs0670483

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  24 in total

1.  Corticotropin releasing hormone and gonadotropin secretion in physically active males after acute exercise.

Authors:  A N Elias; A F Wilson; M R Pandian; G Chune; A Utsumi; R Kayaleh; S C Stone
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

Review 2.  Exercise-induced hormonal changes and their effects upon skeletal muscle tissue.

Authors:  M R Deschenes; W J Kraemer; C M Maresh; J F Crivello
Journal:  Sports Med       Date:  1991-08       Impact factor: 11.136

Review 3.  Physical exercise and psychological well being: a critical review.

Authors:  D Scully; J Kremer; M M Meade; R Graham; K Dudgeon
Journal:  Br J Sports Med       Date:  1998-06       Impact factor: 13.800

Review 4.  Effects of catecholamines on secretion of adrenocorticotrophic hormone (ACTH) in man.

Authors:  S Al-Damluji; L H Rees
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

5.  The responses of the catecholamines and beta-endorphin to brief maximal exercise in man.

Authors:  S Brooks; J Burrin; M E Cheetham; G M Hall; T Yeo; C Williams
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

Review 6.  Hormonal alterations due to exercise.

Authors:  J C Bunt
Journal:  Sports Med       Date:  1986 Sep-Oct       Impact factor: 11.136

Review 7.  Physical exercise and menstrual cycle alterations. What are the mechanisms?

Authors:  H A Keizer; A D Rogol
Journal:  Sports Med       Date:  1990-10       Impact factor: 11.136

8.  Melatonin and gonadotropin secretion after acute exercise in physically active males.

Authors:  A N Elias; A F Wilson; M R Pandian; F J Rojas; R Kayaleh; S C Stone; N James
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

9.  Naloxone and the ventilatory response to exercise in man.

Authors:  C Griffis; R D Kaufman; S A Ward
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1986

10.  Endorphins and exercise.

Authors:  V J Harber; J R Sutton
Journal:  Sports Med       Date:  1984 Mar-Apr       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.